Lv33
330 积分 2024-04-26 加入
Effect of Pembrolizumab Plus Neoadjuvant Chemotherapy on Pathologic Complete Response in Women With Early-Stage Breast Cancer
1小时前
已完结
Disparities in stage at diagnosis for five common cancers in China: a multicentre, hospital-based, observational study
5天前
已完结
Diagnosis and referral of adults with suspected bony metastases
7天前
已关闭
The global burden of lung cancer: current status and future trends
12天前
已完结
Global variations in lung cancer incidence by histological subtype in 2020: a population-based study
12天前
已完结
The role of multidisciplinary team and molecular tumor board in the treatment of a patient with lung cancer
28天前
已完结
Molecular tumour boards — current and future considerations for precision oncology
29天前
已完结
Tailoring neo/adjuvant systemic therapy in breast cancer: “The advent of a personalized approach”—The Breast‐Gynecological and Immuno‐Oncology International Cancer Conference (BGICC) consensus and recommendations
1个月前
已完结
Pembrolizumab for Early Triple-Negative Breast Cancer
1个月前
已完结
Overall Survival with Pembrolizumab in Early-Stage Triple-Negative Breast Cancer
1个月前
已完结
皖公网安备34019202002308
